HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

SAMHD1 Limits the Efficacy of Forodesine in Leukemia by Protecting Cells against the Cytotoxicity of dGTP.

Abstract
The anti-leukemia agent forodesine causes cytotoxic overload of intracellular deoxyguanosine triphosphate (dGTP) but is efficacious only in a subset of patients. We report that SAMHD1, a phosphohydrolase degrading deoxyribonucleoside triphosphate (dNTP), protects cells against the effects of dNTP imbalances. SAMHD1-deficient cells induce intrinsic apoptosis upon provision of deoxyribonucleosides, particularly deoxyguanosine (dG). Moreover, dG and forodesine act synergistically to kill cells lacking SAMHD1. Using mass cytometry, we find that these compounds kill SAMHD1-deficient malignant cells in patients with chronic lymphocytic leukemia (CLL). Normal cells and CLL cells from patients without SAMHD1 mutation are unaffected. We therefore propose to use forodesine as a precision medicine for leukemia, stratifying patients by SAMHD1 genotype or expression.
AuthorsTamara Davenne, Jenny Klintman, Sushma Sharma, Rachel E Rigby, Henry T W Blest, Chiara Cursi, Anne Bridgeman, Bernadeta Dadonaite, Kim De Keersmaecker, Peter Hillmen, Andrei Chabes, Anna Schuh, Jan Rehwinkel
JournalCell reports (Cell Rep) Vol. 31 Issue 6 Pg. 107640 (05 12 2020) ISSN: 2211-1247 [Electronic] United States
PMID32402273 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
CopyrightCopyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.
Chemical References
  • Deoxyguanine Nucleotides
  • Purine Nucleosides
  • Pyrimidinones
  • forodesine
  • deoxyguanosine triphosphate
  • SAM Domain and HD Domain-Containing Protein 1
  • SAMHD1 protein, human
  • Samhd1 protein, mouse
Topics
  • Animals
  • Deoxyguanine Nucleotides (metabolism)
  • Drug Resistance, Neoplasm
  • Female
  • Humans
  • Leukemia, Lymphocytic, Chronic, B-Cell (drug therapy)
  • Male
  • Mice
  • Mice, Inbred C57BL
  • Purine Nucleosides (pharmacology)
  • Pyrimidinones (pharmacology)
  • SAM Domain and HD Domain-Containing Protein 1 (metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: